|
|
|
|
|
|
|
|
|
| |
|
Session Chairs: David Volsky and Bruce Brew |
8:30 am |
Christopher Power (Plenary)
University of Alberta, Edmonton, Alberta, Canada |
Brain lentivirus burden and neurovirulence-strategies for establishing a fine balance |
| |
|
|
9:00 am |
Wenxue Li
National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD, USA
|
Activation of HERV-K expression by HIV-1 infection |
| |
|
|
9:15 am |
David Alvarez-Carbonell
Case Western Reserve University, Cleveland, OH, USA
|
The Nurr1/CoREST transrepression pathway impairs HIV reactivation in latently infected microglial cells
|
| |
|
|
9:30 am |
Andrew MacLean
Tulane University, New Orleans, LA, USA |
Priming the pump: Tat primes astrocytes for subsequent cytokine secretion, quantitative morphological changes and BBB disruption through TLR2 |
|
|
|
|
|
|
| |
|
Introduction by Lynn Pulliam |
| |
Carol Glaser
California Department of Public Health, Richmond, CA, USA |
Overview of infectious encephalitis – Lessons learned from the California Encephalitis Project |
|
|
|
| |
|
Session Chairs: Kelly Jordan-Sciutto and Ron Ellis |
10:35 am |
Ramon Gilberto Gonzalez (Plenary)
Massachusetts General Hospital, Boston, MA, USA |
Neuroimaging of brain viral dynamics and neuronal injury in HAND |
| |
|
|
11:05 am |
Vanessa Pirrone
Drexel University College of Medicine, Philadelphia, PA, USA |
Impact of age on markers of HIV-1 disease |
| |
|
|
11:20 am |
James T. Becker
University of Pittsburgh, Pittsburgh, PA, USA |
MEG-identified recovery of CNS functional connectivity in HIV disease after HAART |
| |
|
|
11:35 am |
Carlos Barrero
Temple University School of Medicine, Philadelphia, PA, USA |
SILAC-based quantitative proteomic approach to identify HIV-1 Vpr mediated changes in macrophage metabolic pathways |
|
|
|
|
|
|
| |
|
Session Chairs: Victor Valcour, Olimpia Meucci |
1:20 pm |
Fatah Kashanchi (Plenary)
George Mason University, Manassas, VA, USA |
Viral miRNA and exosomes: Possible control of cellular signaling pathways in uninfected cells |
| |
|
|
1:50 pm |
José A. Muñoz-Moreno
Germans Trias i Pujol University Hospital, Barcelona, Spain |
Differences in North American and West European study populations when detecting neurocognitive impairment in HIV infection: A comparison of three screening methods |
| |
|
|
2:05 pm |
Walter Royal, III
University of Maryland School of Medicine, Baltimore, MD, USA |
Neurocognitive impairment among treatment-naïve, HIV-infected individuals in Nigeria |
| |
|
|
2:20 pm |
JoEllyn McMillan
University of Nebraska Medical Center, Omaha, NE, USA |
Cell-targeted long-acting nanoformulated antiretroviral therapy |
|
|
|
| |
|
Introduction by Eugene O. Major |
| |
Joan W. Berman
Albert Einstein College of Medicine, Bronx, NY, USA |
Mechanisms of neuroinflammation and toxicity: Critical roles in NeuroAIDS |
|
|
|
|
|
|
| |
|
Session Chairs: Giulio Tarro and Igor Koralnik |
3:25 pm |
Charles S. Cobbs (Plenary)
California Pacific Medical Center, San Francisco, CA, USA |
Emerging role of cytomegalovirus in malignant glioma |
| |
|
|
3:55 pm |
Xin Dang
Beth Israel Deaconess Medical Center, Boston, MA, USA |
JC virus encephalopathy is associated with a novel Agnoprotein-deletion JCV variant |
| |
|
|
4:10 pm |
Te Du
University of Chicago, Chicago, IL, USA |
The activation of latent herpes simplex virus and suppression of LAT and mi-RNAs in trigeminal ganglia within the time-frame of a single cycle of viral replication |
| |
|
|
4:25 pm |
Benjamin Gelman
University of Texas Medical Branch, Galveston, TX, USA |
HIV latency and viral DNA caches in the human brain: Post-integration DNA is highest in specimens obtained prior to HAART and is enriched in white matter |
|
|
|
| |
Panel Discussion |
Moderator: Joan Berman |
| |
|
Panelists: Shilpa Buch, Jennifer Gordon, Diane Lawrence, Aimee Luers, and Susan Morgello |
Shading indicates presentations associated specifically with the 2012 Conference on HIV in the Nervous System
